Market revenue in 2023 | USD 10.6 million |
Market revenue in 2030 | USD 25.9 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Magmaris |
Fastest growing segment | Magmaris |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Magmaris |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Cardinal Health Inc, BIOTRONIK, Meril Life, Abbott Laboratories, Elixirr International PLC Ordinary Shares, REVA Medical, Anteris Technologies Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioresorbable coronary stents market will help companies and investors design strategic landscapes.
Magmaris was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America bioresorbable coronary stents market based on magmaris covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America bioresorbable coronary stents market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America bioresorbable coronary stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account